Observational Study on Costs and Caregiver Burden in Alzheimer's Disease

AstraZeneca

Status: Completed

Conditions: Alzheimer's Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT00698165

EHE 1100

Details and patient eligibility

About

Objective of study is to assess the costs of care, objective and subjective caregiver burden and quality of life in relation to disease severity measured by cognitive function, ADL capabilities and presence of behavioral disturbances in Alzheimer's disease

Enrollment: 2,400 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of possible or probable Alzheimer's disease, with or without vascular elements
• The primary caregiver can be identified
• The patient and his/her primary caregiver are both willing and able to participate in the study

Exclusion criteria

• Patient or caregiver affected by alcohol or narcotics to the extent that it interferes with the completion of the study
• Patient or caregiver does not understand English
• Patient and/ or caregiver is the physician or physician's staff
• Patient and/ or caregiver is a family member of the physician or physician's staff

Trial design

2,400 participants in 2 patient groups

Patients

Description:

1200 adults with mild to severe Alzheimer's disease

Caregivers

Description:

1200 informal caregivers